爱美医疗 FOLD 深 沪
等待开盘 08-02 09:30:00 美东时间
6.32
+0.330
+5.51%
华盛通- 最 高6.35
- 今 开5.96
- 成交量 596.17万股
- 最 低 5.925
- 昨 收 5.99
- 总市值 19.47亿
- 52周最高 12.65
- 市盈率 静 --
- 换手率 1.94%
- 52周最低 5.51
- 委 比 -56.98%
- 总股本 3.08亿
- 历史最高 25.39
- 量 比 1.25
- 振 幅 7.10%
- 历史最低 1.765
- 每 手 1
- 风险率 2.00%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Amicus Therapeutics Affirms FY2025 Sales Guidance of $607.539M-$644.520M vs $620.675M Est
2025 Financial GuidanceAmicus reiterates its financial guidance for 2025, as follows:Total Revenue Growth115% to 22% Galafold Revenue Growth110% to 15% Pombiliti + Opfolda Revenue Growth150% to 65% Gross
07-31 19:14
Amicus Therapeutics Q2 Adj. EPS $0.01 Beats $(0.11) Estimate, Sales $154.688M Beat $147.399M Estimate
Amicus Therapeutics (NASDAQ:FOLD) reported quarterly earnings of $0.01 per share which beat the analyst consensus estimate of $(0.11) by 109.09 percent. This is a 83.33 percent decrease over earnings of $0.06 per share
07-31 19:06
Earnings Scheduled For July 31, 2025
Companies Reporting Before The Bell • Vanguard Extended Duration Treasury ETF (...
07-31 16:32
Here are the major earnings before the open Thursday
Major earnings expected before the bell on Thursday include: AbbVie (OTC:ABBY) Bristol-Myers Squibb Company (BMY) Mastercard Incorporated (MA) CVS Health Corporation (CVS) Shell plc (SHEL) Other earni...
07-31 06:00
Dimerix Secures Major Licensing Deal with Amicus Therapeutics
Dimerix Limited ( ($AU:DXB) ) just unveiled an update. Dimerix Limited announce...
07-25 07:28
Amicus Therapeutics to Announce Second Quarter 2025 Financial Results on July 31, 2025
Amicus Therapeutics will host a conference call and live audio webcast on July 31, 2025, at 8:30 a.m. ET to discuss Q2 2025 financial results. Participants must register online to receive dial-in details, while webcast access is available via the company's Investor Relations website. An archived webcast and slides will be posted shortly after the event.
07-21 11:00
Morgan Stanley Upgrades Amicus Therapeutics to Overweight, Raises Price Target to $108
Morgan Stanley analyst Jeffrey Hung upgrades Amicus Therapeutics (NASDAQ:FOLD) from Equal-Weight to Overweight and raises the price target from $102 to $108.
07-17 19:33
单日暴涨130%+，肾病领域再成行业焦点
转自：新康界 4月30日，诺华公司宣布以17亿美元收购美股上市医药公司Regulus(NASDAQ:RGLS)，受此消息影响，Regulus的股价...
06-23 19:50
金色Web3.0日报 | 美SEC或将介入调查pump.fun
DeFi总市值达1161.49亿美元，24小时交易量为74.61亿美元，锁定资产价值1136.19亿美元。NFT总市值为179.63亿美元，24小时交易量26.53亿美元。美国SEC或调查pump.fun违规行为，过去一年内该平台已遭受集体诉讼。DeFi热点包括Fold Holdings签2.5亿美元融资协议增持比特币，EigenCloud完成7000万美元融资由a16z领投，Starknet完成质押迁移上线Staking v2，币安将支持THORChain网络升级及上线Spark空投。
06-17 13:55
Fold Secures $250 Million Equity Purchase Facility Intended to Expand Bitcoin Treasury Holdings
Fold Holdings, a publicly traded bitcoin financial services company, has entered into a $250 million equity purchase agreement to acquire more bitcoin for its corporate treasury. The company can issue up to $250 million in common stock, subject to SEC registration. Proceeds will primarily be used to purchase additional bitcoin. The Common Stock will be sold in a private placement under the Securities Act of 1933, and the company plans to file a r...
06-17 12:30
